Search Results - "Miller, Megan B"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice by Chakroborty, Shreaya, Goussakov, Ivan, Miller, Megan B, Stutzmann, Grace E

    Published in The Journal of neuroscience (29-07-2009)
    “…Presenilin mutations result in exaggerated endoplasmic reticulum (ER) calcium release in cellular and animal models of Alzheimer's disease (AD). In this study,…”
    Get full text
    Journal Article
  2. 2

    NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice by Goussakov, Ivan, Miller, Megan B, Stutzmann, Grace E

    Published in The Journal of neuroscience (08-09-2010)
    “…Deficits in synaptic function, particularly through NMDA receptors (NMDARs), are linked to late-stage cognitive impairments in Alzheimer's disease (AD). At…”
    Get full text
    Journal Article
  3. 3

    Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease by Chakroborty, Shreaya, Briggs, Clark, Miller, Megan B, Goussakov, Ivan, Schneider, Corinne, Kim, Joyce, Wicks, Jaime, Richardson, Jill C, Conklin, Vincent, Cameransi, Benjamin G, Stutzmann, Grace E

    Published in PloS one (21-12-2012)
    “…Alzheimer's disease (AD) is a devastating neurodegenerative condition with no known cure. While current therapies target late-stage amyloid formation and…”
    Get full text
    Journal Article
  4. 4

    Evaluation of the Phosphoproteome of Mouse Alpha 4/Beta 2-Containing Nicotinic Acetylcholine Receptors In Vitro and In Vivo by Miller, Megan B, Wilson, Rashaun S, Lam, TuKiet T, Nairn, Angus C, Picciotto, Marina R

    Published in Proteomes (15-10-2018)
    “…Activation of nicotinic acetylcholine receptors containing α4 and β2 subunits (α4/β2* nAChRs) in the mammalian brain is necessary for nicotine reinforcement…”
    Get full text
    Journal Article
  5. 5

    NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice by Goussakov, Ivan, Miller, Megan B, Stutzmann, Grace E

    Published in The Journal of neuroscience (08-09-2010)
    “…Deficits in synaptic function, particularly through NMDA receptors (NMDARs), are linked to late-stage cognitive impairments in Alzheimer's disease (AD). At…”
    Get full text
    Journal Article
  6. 6

    Neuronal Rho GEFs in Synaptic Physiology and Behavior by Miller, Megan B., Yan, Yan, Eipper, Betty A., Mains, Richard E.

    Published in The Neuroscientist (Baltimore, Md.) (01-06-2013)
    “…In the mammalian brain, the majority of excitatory synapses are housed in micron-sized dendritic protrusions called spines, which can undergo rapid changes in…”
    Get full text
    Journal Article
  7. 7

    Alternate promoter usage generates two subpopulations of the neuronal RhoGEF Kalirin‐7 by Miller, Megan B., Yan, Yan, Wu, Yi, Hao, Bing, Mains, Richard E., Eipper, Betty A.

    Published in Journal of neurochemistry (01-03-2017)
    “…Kalirin (Kal), a dual Rho GDP/GTP exchange factor (GEF), plays essential roles within and outside the nervous system. Tissue‐specific, developmentally…”
    Get full text
    Journal Article
  8. 8

    An N-terminal Amphipathic Helix Binds Phosphoinositides and Enhances Kalirin Sec14 Domain-mediated Membrane Interactions by Miller, Megan B., Vishwanatha, Kurutihalli S., Mains, Richard E., Eipper, Betty A.

    Published in The Journal of biological chemistry (22-05-2015)
    “…Previous studies revealed an essential role for the lipid-binding Sec14 domain of kalirin (KalSec14), but its mechanism of action is not well understood…”
    Get full text
    Journal Article
  9. 9

    Peptidylglycine α‐amidating monooxygenase heterozygosity alters brain copper handling with region specificity by Gaier, Eric D., Miller, Megan B., Ralle, Martina, Aryal, Dipendra, Wetsel, William C., Mains, Richard E., Eipper, Betty A.

    Published in Journal of neurochemistry (01-12-2013)
    “…Copper (Cu), an essential trace element present throughout the mammalian nervous system, is crucial for normal synaptic function. Neuronal handling of Cu is…”
    Get full text
    Journal Article
  10. 10

    Nonenzymatic domains of Kalirin7 contribute to spine morphogenesis through interactions with phosphoinositides and Abl by Ma, Xin-Ming, Miller, Megan B, Vishwanatha, K S, Gross, Maegan J, Wang, Yanping, Abbott, Thomas, Lam, Tukiet T, Mains, Richard E, Eipper, Betty A

    Published in Molecular biology of the cell (01-05-2014)
    “…Like several Rho GDP/GTP exchange factors (GEFs), Kalirin7 (Kal7) contains an N-terminal Sec14 domain and multiple spectrin repeats. A natural splice variant…”
    Get full text
    Journal Article
  11. 11

    Brain Region and Isoform-Specific Phosphorylation Alters Kalirin SH2 Domain Interaction Sites and Calpain Sensitivity by Miller, Megan B, Yan, Yan, Machida, Kazuya, Kiraly, Drew D, Levy, Aaron D, Wu, Yi I, Lam, TuKiet T, Abbott, Thomas, Koleske, Anthony J, Eipper, Betty A, Mains, Richard E

    Published in ACS chemical neuroscience (19-07-2017)
    “…Kalirin7 (Kal7), a postsynaptic Rho GDP/GTP exchange factor (RhoGEF), plays a crucial role in long-term potentiation and in the effects of cocaine on behavior…”
    Get full text
    Journal Article
  12. 12

    Alternate promoter usage generates two subpopulations of the neuronal Rho GEF Kalirin‐7 by Miller, Megan B., Yan, Yan, Wu, Yi, Hao, Bing, Mains, Richard E., Eipper, Betty A.

    Published in Journal of neurochemistry (01-03-2017)
    “…Abstract Kalirin (Kal), a dual Rho GDP / GTP exchange factor ( GEF ), plays essential roles within and outside the nervous system. Tissue‐specific,…”
    Get full text
    Journal Article
  13. 13

    Peptidylglycine [alpha]-amidating monooxygenase heterozygosity alters brain copper handling with region specificity by Gaier, Eric D, Miller, Megan B, Ralle, Martina, Aryal, Dipendra, Wetsel, William C, Mains, Richard E, Eipper, Betty A

    Published in Journal of neurochemistry (01-12-2013)
    “…Copper (Cu), an essential trace element present throughout the mammalian nervous system, is crucial for normal synaptic function. Neuronal handling of Cu is…”
    Get full text
    Journal Article
  14. 14

    Pam (Peptidylglycine α-amidating monooxygenase) heterozygosity alters brain copper handling with region specificity by Gaier, Eric D, Miller, Megan B, Ralle, Martina, Aryal, Dipendra, Wetsel, William C, Mains, Richard E, Eipper, Betty A

    Published in Journal of neurochemistry (13-10-2013)
    “…Copper (Cu), an essential trace element present throughout the mammalian nervous system, is crucial for normal synaptic function. Neuronal handling of Cu is…”
    Get full text
    Journal Article
  15. 15

    NMDA-Mediated Ca 2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice by Goussakov, Ivan, Miller, Megan B., Stutzmann, Grace E.

    Published in The Journal of neuroscience (08-09-2010)
    “…Deficits in synaptic function, particularly through NMDA receptors (NMDARs), are linked to late-stage cognitive impairments in Alzheimer's disease (AD). At…”
    Get full text
    Journal Article
  16. 16

    Neuronal RhoGEFs in synaptic physiology and behavior by Miller, Megan B., Yan, Yan, Eipper, Betty A., Mains, Richard E.

    Published in The Neuroscientist (Baltimore, Md.) (11-02-2013)
    “…In the mammalian brain the majority of excitatory synapses are housed in micron-sized dendritic protrusions called spines, which can undergo rapid changes in…”
    Get full text
    Journal Article
  17. 17

    Stabilizing ER Ca.sup.2+ Channel Function as an Early Preventative Strategy for Alzheimer's Disease by Chakroborty, Shreaya, Briggs, Clark, Miller, Megan B, Goussakov, Ivan, Schneider, Corinne, Kim, Joyce, Wicks, Jaime, Richardson, Jill C, Conklin, Vincent, Cameransi, Benjamin G, Stutzmann, Grace E

    Published in PloS one (21-12-2012)
    “…Alzheimer's disease (AD) is a devastating neurodegenerative condition with no known cure. While current therapies target late-stage amyloid formation and…”
    Get full text
    Journal Article
  18. 18